2023-08-24T15:44:03-05:00 2022-12-31 910189318 MOSS ADAMS LLP 101 SECOND STREET SUITE 900 SAN FRANCISCO CA 94105 990 2022-01-01 273868699 AMERICAN GLAUCOMA SOCIETY FOUNDATION AMER 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 GREGORY L SKUTA MD EXECUTIVE VICE PRESIDENT 4155618587 2023-08-24 1 GREGORY SKUTA MD 999009999 0 MICHAEL LUMSDEN P01262236 4159561500 2023-08-10 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z LEON W HERNDON JR MD 655 BEACH STREET SAN FRANCISCO CA 94109 157415 0 X WWW.AMERICANGLAUCOMASOCIETY.NET X 2010 CA TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 22 22 0 28 0 0 358752 156026 0 0 2400 1376 0 0 361152 157402 240000 290000 0 0 0 0 0 0 0 21316 16387 261316 306387 99836 -148985 494708 331194 8259 6673 486449 324521 X TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 0 0 150000 150000 0 AGSF PROVIDED THE AMERICAN GLAUCOMA SOCIETY (AGS) $150,000 IN FUNDING TO SUPPORT THE MENTORING FOR THE ADVANCEMENT OF PHYSICIANS AND SCIENTISTS (MAPS) AWARDS. THE MAPS PROGRAM IS A MULTI-FACETED MENTORING PROGRAM PREDOMINANT IN FULFILLING THE MISSION OF AGS BY SUPPORTING GLAUCOMA SPECIALISTS AND SCIENTISTS TO FURTHER THEIR CAREERS IN SCIENCE AND RESEARCH OF GLAUCOMA. THE FUNDING OF THIS AWARD PROVIDES AGS A VEHICLE TO EXPAND ITS REACH TO YOUNG-PHYSICIAN SCIENTISTS AND FOCUS ON PROVIDING TOOLS AND RESOURCES TO FURTHER THEIR CAREERS AS POTENTIAL LEADERS IN THE SPECIALTY OF GLAUCOMA CARE. 60000 60000 0 AGSF PROVIDED AGS $60,000 IN FUNDING TO SUPPORT RESEARCH AND EDUCATION PROGRAMS SPONSORED BY AGS AIMED AT MAKING A SIGNIFICANT IMPACT IN THE FIGHT TO PREVENT BLINDNESS AND VISUAL IMPAIRMENT. EXAMPLES INCLUDE: (I) GRANTS TO YOUNG CLINICIAN SCIENTISTS TO ENCOURAGE THE DEVELOPMENT OF YOUNG CLINICIAN SCIENTISTS IN GLAUCOMA BY PROVIDING FUNDING FOR RESEARCH PROJECTS WITHIN THE FIRST 5 YEARS AFTER GRADUATION, AND (II) GRANTS TO MID-CAREER PHYSICIAN SCIENTISTS TO ALLOW MID-CAREER (BETWEEN 5 AND 20 YEARS AFTER FELLOWSHIP) TO INITIATE NEW RESEARCH OR CONTINUE ONGOING RESEARCH. 75000 75000 0 AGSF PROVIDED AGS $75,000 IN FUNDING TO SUPPORT AGS CARES WHICH IS A PUBLIC SERVICE PROGRAM SUPPORTED BY THE AGS FOUNDATION THAT IS DEDICATED TO PROVIDING SURGICAL GLAUCOMA CARE AT NO COST TO UNINSURED OR UNDER-SERVED PATIENTS WHO QUALIFY FOR SUCH CARE. THE GLAUCOMA CARE IS PROVIDED BY MEMBERS OF A NATIONAL NETWORK OF VOLUNTEERS COMPRISING GLAUCOMA SURGEONS WHO ARE AGS ACTIVE OR PROVISIONAL MEMBERS. 5000 5000 0 AGSF PROVIDED SUPPORT TO OUTSIDE ORGANIZATIONS (THE FOUNDATION OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY) WORKING CLOSELY WITH EYE HEALTH TO SUPPORT OPERATIONS. 5000 5000 0 290000 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 22 22 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X TIM LOSCH 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 X RONALD L FELLMAN MD PRES THRU 3/2022 / PAST PRESIDENT 1.00 1.00 X X 0 0 0 CHRISTOPHER A GIRKIN MD MSPH VP THRU 3/2022 / PRES START 3/2022 1.00 1.00 X X 0 0 0 LEON W HERNDON JR MD SECR. THRU 3/2022 / VP START 3/2022 1.00 1.00 X X 0 0 0 JOANN A GIACONI MD SECRETARY START 3/2022 1.00 1.00 X X 0 0 0 LISA FRAN ROSENBERG MD TREASURER 1.00 1.00 X X 0 0 0 LAMA A AL-ASWAD MD MPH MEMBER-AT-LARGE START 3/2022 1.00 1.00 X 0 0 0 WALLACE LM ALWARD MD MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 JAMES D BRANDT MD MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 DONALD L BUDENZ MD MPH PAST PRESIDENT 1.00 1.00 X 0 0 0 LOUIS B CANTOR MD MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 PRATAP CHALLA MD MEMBER-AT-LARGE THRU 3/2022 1.00 1.00 X 0 0 0 GEOFFREY T EMERICK MD PATIENT COMMITTEE CHAIR START 3/2022 1.00 1.00 X 0 0 0 STEVEN J GEDDE MD EDUCATION AND COMM CHAIR THRU 3/2022 1.00 1.00 X 0 0 0 DAVINDER S GROVER MD MPH MEMBER-AT-LARGE THRU 3/2022 1.00 1.00 X 0 0 0 DALE K HEUER MD PAST PRESIDENT THRU 3/2022 1.00 1.00 X 0 0 0 RICHARD K LEE MD PHD RESEARCH COMMITTEE CHAIR 1.00 1.00 X 0 0 0 MICHELE C LIM MD PROGRAM COMMITTEE CHAIR START 3/2022 1.00 1.00 X 0 0 0 FELIPE A MEDEIROS MD PHD BYLAWS/STRAT PLANNING COMM CHAIR START 3/2022 1.00 1.00 X 0 0 0 KELLY W MUIR MD EDUCATION AND COMMUNICATION CHAIR 1.00 1.00 X 0 0 0 MILDRED MG OLIVIER MD MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 PRADEEP Y RAMULU MD PHD NOMINATING/PROG COMM CHAIR THRU 3/2022 1.00 1.00 X 0 0 0 KULDEV SINGH MD MPH MEMBER-AT-LARGE 1.00 0.00 X 0 0 0 SAMUEL P SOLISH MD COUNCILOR TO AAO START 3/2022 1.00 1.00 X 0 0 0 JOSHUA D STEIN MD MS PATIENT COMMITTEE CHAIR THRU 3/2022 1.00 1.00 X 0 0 0 ANGELA V TURALBA MD MMS MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 THASARAT S VAJARANANT MD LEAD AMBASSADOR 1.00 1.00 X 0 0 0 KATEKI VINOD MD MEMBER-AT-LARGE START 3/2022 1.00 1.00 X 0 0 0 JANEY WIGGS MD PHD NOMINATING COMMITTEE CHAIR START 3/2022 1.00 1.00 X 0 0 0 0 0 0 0 0 0 0 0 156026 156026 1253 1253 136 13 123 123 123 157402 0 0 1376 290000 290000 8724 8724 3900 3900 616 616 1042 1042 PRINTING/PUBLICATIONS 2105 2105 306387 290000 16387 0 396158 229987 83305 74839 15245 26368 494708 331194 8259 6673 8259 6673 X 480224 319521 6225 5000 486449 324521 494708 331194 -148985 -12943 0 X 0 1 X 1 0 X 304516 252739 253549 358752 156026 1325582 304516 252739 253549 358752 156026 1325582 717768 607814 1166 1319 9821 1234 1253 14793 1340375 0.45350 0.36930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE FROM RELATED ORGANIZATION 26368 26368 1 AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 501(C)(3) 285000 0 RESEARCH, MENTORING, AND PUBLIC SERVICE GRANTS 1 0 PART I, LINE 2: THE ORGANIZATION'S BOARD IS INTIMATELY INVOLVED WITH THE WORK OF THE GRANT RECIPIENT, AMERICAN GLAUCOMA SOCIETY, INC. (AGS). THE BOARD OF DIRECTORS OF AGS IS COMPRISED SOLELY OF MEMBERS WHO ALSO SIT ON THE BOARD OF AGSF; THUS, GRANTS TO AGS ARE MONITORED VIA OVERLAPPING GOVERNANCE. FORM 990, PART VI, SECTION A, LINE 3 AGSF HAS A MANAGEMENT CONTRACT WITH SAN FRANCISCO ASSOCIATION MANAGEMENT SERVICES (SF-AMS). UNDER THE ANNUAL CONTRACT, ALL PERSONNEL DECISIONS AND FINANCIAL OPERATIONS ARE THE RESPONSIBILITY OF SF-AMS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION DOES NOT HAVE "MEMBERS" BY DEFINITION OF THE BYLAWS. HOWEVER, THE FORM 990 INSTRUCTIONS DEFINE A "MEMBER" AS ANY PERSON (INCLUDING A CORPORATION OR OTHER LEGAL ENTITY) WHO, PURSUANT TO A PROVISION IN THE ORGANIZATION'S GOVERNING DOCUMENTS, HAS THE RIGHT TO PARTICIPATE IN THE ORGANIZATION'S GOVERNANCE, INCLUDING ELECTING MEMBERS OF THE GOVERNING BODY. ACCORDINGLY, AGSF HAS ONE SOLE MEMBER: AMERICAN GLAUCOMA SOCIETY, INC. FORM 990, PART VI, SECTION A, LINE 7A ALL OF THE DIRECTORS OF THE AMERICAN GLAUCOMA SOCIETY, INC. (AGS), A CALIFORNIA NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, SHALL AUTOMATICALLY BE DIRECTORS OF THIS CORPORATION, BUT ONLY FOR SO LONG AS THEY REMAIN DIRECTORS OF AGS. THE DIRECTORS OF AGS MAY ALSO APPOINT UP TO FIVE ADDITIONAL DIRECTORS TO THE BOARD OF AGSF. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE TAX PROFESSIONAL. THE FORM IS THEN REVIEWED BY THE FINANCE AND ACCOUNTING STAFF OF THE ORGANIZATION'S MANAGEMENT COMPANY, WITH QUESTIONS REFERRED TO THE OUTSIDE TAX PROFESSIONAL. AFTER A FULL REVIEW (WITH MODIFICATIONS WHERE NECESSARY), THE FINAL VERSION OF THE FORM 990 IS PROVIDED TO ALL MEMBERS OF THE ORGANIZATION'S VOTING GOVERNING BODY PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C IT IS THE POLICY OF THE BOARD OF DIRECTORS OF AGSF THAT ITS DIRECTORS DISCLOSE AND, DEPENDING ON THE CIRCUMSTANCES, AVOID ANY AND ALL POSSIBLE CONFLICTS OF INTEREST. A DIRECTOR HAS A CONFLICT OF INTEREST WHEN A PERSON OR A MEMBER OF HIS OR HER FAMILY HAS A RELATIONSHIP WITH, OR AN INTEREST IN, AN ENTITY THAT DOES BUSINESS WITH AGSF OR IS A COMPETITOR OF AGSF. THIS POLICY IS IMPLEMENTED AND ENFORCED SO AS TO PREVENT THE JUDGMENT OF THE BOARD FROM BEING INFLUENCED BY AN ECONOMIC RELATIONSHIP IN WHICH A DIRECTOR OF HIS/HER FAMILY IS PERSONALLY INVOLVED. DIRECTORS SATISFY TWO OBLIGATIONS IN REGARDS TO THIS CONFLICT OF INTEREST POLICY: (1) ASCERTAINING AND DISCLOSING THEIR OWN FAMILY CONFLICTS, AND (2) DETERMINING WHETHER ANOTHER INVOLVED PERSON SHOULD PARTICIPATE IN DELIBERATIONS AND/OR VOTING ON AN ISSUE WITH RESPECT TO WHICH HE/SHE HAS A CONFLICT. A DIRECTOR WILL DISCLOSE ANY CONFLICT AT BOARD MEETINGS AND RECUSE THEMSELVES IF SUCH CONFLICT EXISTS. TO ACCOMPLISH AND FULFILL THIS POLICY, ALL DIRECTORS ANNUALLY SUBMIT A DISCLOSURE STATEMENT, AND ARE RESPONSIBLE FOR UPDATING THE STATEMENT IF CHANGES OCCUR DURING THE YEAR. FORM 990, PART VI, SECTION C, LINE 19 AGSF MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 TO PROMOTE THE IMPROVEMENT AND EXCHANGE OF GLAUCOMA-RELATED INFORMATION CA 501(C)(3) LINE 10 N/A 1 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 AMERICAN GLAUCOMA SOCIETY INC B 285000 BOOK VALUE